Edward Zecchini Sells Shares of Cryoport, Inc. $CYRX

Key Points

  • Edward Zecchini sold 33,600 shares of Cryoport, Inc. ($CYRX) worth $486,192.
  • $CYRX last traded around $14.62.

Edward Zecchini, Chief Digital and Tech Officer at Cryoport, Inc. ($CYRX), sold 33,600 shares at an average price of $14.47, for a total transaction of $486,192. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Cryoport, Inc. ($CYRX) Stock

Last price$14.62
Market cap$736.88M
Forward P/E-23.58
PEG ratio62.13
Beta1.89
52-week low$6.16
52-week high$16.73
50-day MA$12.38
200-day MA$10.04
Current ratio2.09
Quick ratio1.97
Debt-to-equity0.47

Cryoport, Inc. Earnings

EPS (ttm)$-0.90
Revenue (ttm)$182.94M
Revenue growth16.5%
Net margin43.6%
Return on equity-8.2%
Next earningsAug 4, 2026

Analysts Set New Price Targets

ConsensusStrong Buy
Average target$15.61
High target$20.00
Low target$12.00
Analysts covering9

About Cryoport, Inc.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

ExchangeNasdaqCM
SectorIndustrials
IndustryIntegrated Freight & Logistics
HeadquartersBrentwood, TN
CEOMr. Jerrell W. Shelton
Employees684

See Also

This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.